Alexandria Real Estate Equities
ARE
#2383
Rank
HK$61.36 B
Marketcap
HK$352.13
Share price
-2.60%
Change (1 day)
-38.03%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -HK$4.78 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are HK$2.85 Billion. In 2025 the company made an earning of -HK$7.76 Billion a decrease over its 2024 earnings that were of HK$5.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$4.78 Billion-38.45%
2025 -HK$7.76 Billion-242.13%
2024 HK$5.45 B96.11%
2023 HK$2.78 B-53.56%
2022 HK$5.98 B-3.96%
2021 HK$6.23 B-20.26%
2020 HK$7.82 B72.88%
2019 HK$4.52 B3.11%
2018 HK$4.38 B73.54%
2017 HK$2.52 B464.88%
2016 HK$0.44 B-77.32%
2015 HK$1.97 B36.31%
2014 HK$1.44 B-10.81%
2013 HK$1.62 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$82.93 B-1,817.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$243.71 B-5,147.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$71.15 B-1,573.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$76.71 B-1,688.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$9.08 B-288.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$75.14 B-1,656.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$6.80 B-241.04%๐Ÿ‡บ๐Ÿ‡ธ USA